Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J FORMAN

Showing results (851-860 of 1,290) with videos related to

Pageof 129
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2019
Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria ClonesMatthew Mei, Rohan Gupta, Margaret O'Donnell, et al.
Leukemia & Lymphoma|February 29, 2012
Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failureNitya Nathwani, Amrita Y Krishnan, Qin Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membraneScott E James, Philip D Greenberg, Michael C Jensen, et al.
Transplantation|August 27, 2019
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA MismatchMonzr M Al Malki, Ketevan Gendzekhadze, Dongyun Yang, et al.
Blood Advances|June 17, 2024
Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignanciesZhengyuan Dong, L Elizabeth Budde, Elizabeth Oh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patientsJoel Y Sun, Andrew Dagis, Laima Gaidulis, et al.
Stem Cell Research & Therapy|April 19, 2023
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective studyDat Ngo, Jason Chen, Jose Tinajero, et al.
Journal of Education and Health Promotion|February 9, 2024
Evaluating the utility of a global webinar for mentoring medical students and OBGYN residents in REIEliana Fine, Valerie R Libby, Eduardo Hariton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal StudyNoha Sharafeldin, Alysia Bosworth, Sunita K Patel, et al.
British Journal of Haematology|August 24, 2019
Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemiaIbrahim Aldoss, Jianying Zhang, Raju Pillai, et al.
Pageof 129

Showing results (851-860 of 1,290) with videos related to

Sort By:
Pageof 129
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2019
Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria ClonesMatthew Mei, Rohan Gupta, Margaret O'Donnell, et al.
Leukemia & Lymphoma|February 29, 2012
Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failureNitya Nathwani, Amrita Y Krishnan, Qin Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membraneScott E James, Philip D Greenberg, Michael C Jensen, et al.
Transplantation|August 27, 2019
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA MismatchMonzr M Al Malki, Ketevan Gendzekhadze, Dongyun Yang, et al.
Blood Advances|June 17, 2024
Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignanciesZhengyuan Dong, L Elizabeth Budde, Elizabeth Oh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patientsJoel Y Sun, Andrew Dagis, Laima Gaidulis, et al.
Stem Cell Research & Therapy|April 19, 2023
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective studyDat Ngo, Jason Chen, Jose Tinajero, et al.
Journal of Education and Health Promotion|February 9, 2024
Evaluating the utility of a global webinar for mentoring medical students and OBGYN residents in REIEliana Fine, Valerie R Libby, Eduardo Hariton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal StudyNoha Sharafeldin, Alysia Bosworth, Sunita K Patel, et al.
British Journal of Haematology|August 24, 2019
Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemiaIbrahim Aldoss, Jianying Zhang, Raju Pillai, et al.
Pageof 129